Ovarian hyperstimulation syndrome following GnRH agonist trigger—think ectopic (original) (raw)
Empty follicle syndrome after GnRH agonist triggering: Is it possible to res- cue with hCG? Two cases and review of the literature
Funda Gode
2015
View PDFchevron_right
Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome
Walter Vegetti
Human Reproduction, 2005
View PDFchevron_right
Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome
murat sonmezer
Reproductive BioMedicine Online, 2017
View PDFchevron_right
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
Evangelos Papanikolaou, Michel Camus
Fertility and Sterility, 2006
View PDFchevron_right
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
Claudio Benadiva
Fertility and Sterility, 2008
View PDFchevron_right
Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol
Manish Banker, Shahar Kol
Fertility and Sterility, 2014
View PDFchevron_right
Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles
Anne Zedeler
Human Reproduction, 2016
View PDFchevron_right
GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
Carmina Vidal, Juan Giles
International Journal of Endocrinology and Metabolism, 2013
View PDFchevron_right
Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications
Shahar Kol
Human Reproduction
View PDFchevron_right
Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile
Evangelos Papanikolaou, Michel Camus
Human Reproduction, 2005
View PDFchevron_right
Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome
Francisco Delgado
Fertility and Sterility, 2011
View PDFchevron_right
GnRH-Agonist Ovulation Trigger in Patients Undergoing Controlled Ovarian Hyperstimulation for IVF with Stop GnRH-Agonist Combined with Multidose GnRH-Antagonist Protocol
Raoul Orvieto
Gynecologic and Obstetric Investigation, 2021
View PDFchevron_right
Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report
Diederick de Jong
Journal of Assisted Reproduction and Genetics
View PDFchevron_right
Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
ayten türkkanı
Gynecology Obstetrics and Reproductive Medicine, 2016
View PDFchevron_right
Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom?
Raoul Orvieto
Journal of Ovarian Research, 2015
View PDFchevron_right
Evaluation of role of gnrh antagonist in intrauterine insemination (IUI) cycles with mild ovarian hyperstimulation (MOH)
Sarika Arora
Fertility and Sterility, 2013
View PDFchevron_right
Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases
Necati Özçimen
Reproductive biomedicine online, 2014
View PDFchevron_right
Endocrinology: Ovarian hyperstimulation syndrome associated with spontaneous pregnancy
Joseph Schenker
Human Reproduction, 1996
View PDFchevron_right
Ovarian Hyperstimulation Syndrome in Natural Conception
Sheena Chopra
Current Trends in diagnosis & Treatment, 2018
View PDFchevron_right
Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study
Stamatina Iliodromiti
View PDFchevron_right
Substituting HCG with GnRH agonist to trigger final follicular maturation – a retrospective comparison of three different ovarian stimulation protocols
Roy Homburg
Reproductive BioMedicine Online, 2006
View PDFchevron_right
Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome
Leyre Herrero
Fertility and Sterility, 2011
View PDFchevron_right
GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study
Juan Giles
Fertility and Sterility, 2009
View PDFchevron_right
GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study
Raoul Orvieto
Human Reproduction, 2020
View PDFchevron_right
Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting
John Nulsen
Fertility and Sterility, 2010
View PDFchevron_right
Unexpected Pregnancy and Ovarian Hyperstimulation Syndrome Following Ivf Cycle with all Embryos Frozen: A Case Report
Hong-Nerng Ho
Taiwanese Journal of Obstetrics and Gynecology, 2005
View PDFchevron_right
Gonadotropin-Releasing Hormone Agonist Trigger: The Way to Eliminate Ovarian Hyperstimulation Syndrome—A 20-Year Experience
Bulent Gulekli
Seminars in Reproductive Medicine, 2010
View PDFchevron_right
GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori
Shimon Scharf, Raoul Orvieto
Fertility and Sterility, 2009
View PDFchevron_right
Empty follicle syndrome after GnRH agonist trigger, rescued with HCG in a donor oocyte with successful pregnancy outcome: a case report
KUNDAVI SHANKAR
International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2016
View PDFchevron_right
The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial
Donatella Caserta
Human Reproduction, 2011
View PDFchevron_right
Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma
Raoul Orvieto
Journal of ovarian research, 2013
View PDFchevron_right